+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Disease Diagnosis Market - Global Forecast 2026-2032- Product Image
Heart Disease Diagnosis Market - Global Forecast 2026-2032- Product Image
Sale

Heart Disease Diagnosis Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6282275
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Heart Disease Diagnosis: Executive Summary

Heart disease diagnosis encompasses the detection, classification, and monitoring of cardiovascular conditions through clinical assessment, laboratory testing, imaging, electrophysiology, and remote monitoring. Diagnostic pathways increasingly combine risk-factor evaluation with noninvasive tests and targeted follow-up, supporting earlier identification of coronary, structural, rhythm-related, and heart-failure conditions. Demand is shaped by ageing populations, persistent cardiometabolic risk, uneven access to specialists, and the need to improve diagnostic accuracy across care settings.

Diagnostic Care Is Shifting Toward Earlier, Connected Assessment

The diagnostic landscape is moving from episodic, symptom-led evaluation toward risk-based and longitudinal assessment. Portable ultrasound, ambulatory electrocardiography, advanced imaging, and connected monitoring are extending diagnostic capabilities beyond specialist facilities. At the same time, integrated care pathways are linking primary care, emergency services, cardiology, and rehabilitation. This transition creates opportunities to reduce delays, but it also increases the importance of clinical governance, interoperability, data quality, reimbursement alignment, and equitable access.

Artificial Intelligence Strengthens Triage, Interpretation, and Follow-Up

Artificial intelligence is being applied to electrocardiogram interpretation, image analysis, risk stratification, workflow prioritization, and identification of patients requiring additional testing. Its cumulative impact depends on high-quality, representative datasets; transparent validation; clinician oversight; and compatibility with existing clinical systems. AI can help address workforce constraints and standardize routine interpretation, but it does not eliminate the need for contextual clinical judgment. Leaders should prioritize prospective evaluation, bias monitoring, cybersecurity, explainability, and clear accountability for false-positive and false-negative results.

Regional Differences Reflect Access, Infrastructure, and Care-Pathway Maturity

North America combines advanced imaging, specialist capacity, and extensive digital-health adoption, while facing fragmentation and affordability challenges. Europe benefits from strong clinical standards and public-health infrastructure, although access and data integration vary across countries. Asia-Pacific contains highly developed diagnostic systems alongside substantial rural and capacity gaps. Latin America is emphasizing earlier detection and expanded outpatient access amid uneven infrastructure. The Middle East is investing in specialized facilities, digital systems, and preventive programs, while Africa continues to confront shortages of equipment, specialists, and referral capacity, making portable and decentralized approaches particularly relevant.

Cross-Group Priorities Vary Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries share a need to expand affordable screening, referral networks, and workforce capability across diverse health systems. BRICS members face substantial internal variation but commonly prioritize scalable diagnostics, domestic technical capacity, and access outside major cities. The European Union emphasizes harmonized evidence, interoperability, and equitable cross-border care. G7 systems generally focus on innovation, aging-related disease burden, quality improvement, and responsible AI adoption. GCC countries are strengthening specialized care, prevention, and digital health infrastructure. NATO members also benefit from collaboration on medical readiness, resilience, cybersecurity, and continuity of care during emergencies.

Country Context Shapes Diagnostic Priorities and Implementation

Australia is emphasizing distributed care and digital connectivity across geographically dispersed populations. Brazil and Mexico face the challenge of extending reliable diagnostics beyond metropolitan centers. Canada must address distance, workforce distribution, and coordination across provinces. China and India are combining technology adoption with broad efforts to improve accessibility and referral systems. France, Germany, Italy, Spain, and the United Kingdom are balancing established clinical infrastructure with aging populations, workforce pressures, and health-system integration. Japan and South Korea are advancing technology-enabled care amid demographic aging. Russia’s priorities include maintaining diagnostic capacity across large territories and strengthening system resilience. The United States continues to focus on advanced testing, prevention, interoperability, and affordability.

Industry Leaders Should Build Trustworthy, Accessible Diagnostic Pathways

Leaders should design diagnostic services around complete patient pathways rather than isolated devices or tests. Priorities include strengthening primary-care risk assessment, deploying validated point-of-care tools where specialist access is limited, integrating imaging and laboratory data, and establishing rapid referral protocols. Organizations should evaluate AI in real-world populations, maintain human oversight, and monitor performance across demographic groups. Partnerships with clinicians, health systems, regulators, payers, and patient organizations can improve adoption. Operational plans should also address cybersecurity, staff training, maintenance, data governance, and continuity of service in underserved or disrupted settings.

Methodology: Evidence-Based Synthesis of Diagnostic Trends and System Context

This executive summary uses a structured qualitative synthesis of established clinical, technological, demographic, and health-system factors relevant to heart disease diagnosis. Analysis is organized by transformation themes, AI applications, required regions, country groups, and specified countries. Insights are framed around documented patterns in diagnostic practice, infrastructure, access, regulation, and care delivery rather than unsupported numerical claims. The assessment excludes market estimates, market shares, forecasts, and company-specific analysis, and should be complemented with local clinical guidelines, regulatory sources, and implementation evidence before investment or policy decisions.

The Next Phase of Heart Disease Diagnosis Will Depend on Integration and Equity

Heart disease diagnosis is becoming more connected, earlier, and increasingly supported by automation, but progress will depend on more than technical capability. Reliable outcomes require coordinated pathways, skilled professionals, interoperable data, rigorous validation, and equitable access to testing and follow-up. Regional and national priorities differ, yet the common strategic objective is clear: combine innovation with clinical accountability and resilient delivery so that accurate diagnosis reaches patients promptly, regardless of location or socioeconomic status.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Heart Disease Diagnosis Market, by Disease Type
7.1. Introduction
7.2. Coronary Artery Disease
7.3. Arrhythmia
7.4. Heart Failure
7.5. Valvular Heart Disease
7.6. Congenital Heart Disease
7.7. Cardiomyopathy
7.8. Peripheral Artery Disease
7.9. Ischemic Heart Disease
7.10. Rheumatic Heart Disease
7.11. Pulmonary Heart Disease
7.12. Hypertensive Heart Disease
7.13. Myocarditis
7.14. Endocarditis
7.15. Pericardial Disease
8. Heart Disease Diagnosis Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Specialty Cardiac Centers
8.4. Diagnostic Laboratories
8.5. Ambulatory Surgical Centers
8.6. Clinics
8.7. Home Healthcare Settings
8.8. Research Institutes
8.9. Academic Medical Centers
9. Heart Disease Diagnosis Market, by Distribution Channel
9.1. Introduction
9.2. Online
9.3. Offline
10. Heart Disease Diagnosis Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Heart Disease Diagnosis Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Heart Disease Diagnosis Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Abbott Laboratories
14.2. AliveCor Inc
14.3. Bio-Rad Laboratories Inc
14.4. BIOTRONIK SE & Co. KG
14.5. Boston Scientific Corporation
14.6. Cardinal Health Inc
14.7. Danaher Corporation
14.8. Edwards Lifesciences Corporation
14.9. F. Hoffmann-La Roche Ltd
14.10. FUJIFILM Holdings Corporation
14.11. GE HealthCare Technologies Inc
14.12. Getinge AB
14.13. HeartFlow Inc
14.14. Hitachi Ltd
14.15. iRhythm Technologies Inc
14.16. Johnson & Johnson
14.17. Koninklijke Philips N.V.
14.18. Medtronic plc
14.19. MicroPort Scientific Corporation
14.20. Nihon Kohden Corporation
14.21. Quest Diagnostics Incorporated
14.22. Schiller AG
14.23. Siemens Healthineers AG
14.24. Terumo Corporation
14.25. Thermo Fisher Scientific Inc
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Heart Disease Diagnosis Market, Years Considered for the Study
FIGURE 2. Global Heart Disease Diagnosis Market, Research Design
FIGURE 3. Global Heart Disease Diagnosis Market, Research Framework
FIGURE 4. Global Heart Disease Diagnosis Market, Data Triangulation
FIGURE 5. Global Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Heart Disease Diagnosis Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 7. Global Heart Disease Diagnosis Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Heart Disease Diagnosis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Heart Disease Diagnosis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Heart Disease Diagnosis Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Heart Disease Diagnosis Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Heart Disease Diagnosis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Heart Disease Diagnosis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Heart Disease Diagnosis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Heart Disease Diagnosis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Heart Disease Diagnosis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Heart Disease Diagnosis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Heart Disease Diagnosis Market Segmentation & Coverage
TABLE 2. Global Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 4. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Arrhythmia Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Arrhythmia Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Arrhythmia Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Valvular Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Valvular Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Valvular Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Congenital Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Congenital Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Congenital Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cardiomyopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cardiomyopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cardiomyopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Peripheral Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Peripheral Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Peripheral Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Ischemic Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Ischemic Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Ischemic Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Rheumatic Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Rheumatic Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Rheumatic Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Pulmonary Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Pulmonary Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Pulmonary Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Hypertensive Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Hypertensive Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Hypertensive Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Myocarditis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Myocarditis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Myocarditis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Endocarditis Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Endocarditis Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Endocarditis Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Pericardial Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Pericardial Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Pericardial Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Specialty Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Specialty Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Specialty Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Home Healthcare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Home Healthcare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Home Healthcare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Academic Medical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Academic Medical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Academic Medical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. North America Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. North America Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 85. North America Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. North America Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. Latin America Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Latin America Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 89. Latin America Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Latin America Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Europe Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Europe Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 93. Europe Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Europe Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Middle East Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Middle East Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 97. Middle East Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Middle East Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Africa Heart Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Africa Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 101. Africa Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Africa Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. Global Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 106. ASEAN Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. ASEAN Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. GCC Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. GCC Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 110. GCC Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. European Union Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. European Union Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 114. European Union Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. European Union Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. BRICS Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. BRICS Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 118. BRICS Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. BRICS Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. G7 Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. G7 Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 122. G7 Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. G7 Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. NATO Heart Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. NATO Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 126. NATO Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. NATO Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Global Heart Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. United States Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 130. United States Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 131. United States Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. United States Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. Canada Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 134. Canada Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 135. Canada Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Canada Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. Mexico Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 138. Mexico Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 139. Mexico Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Mexico Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Brazil Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 142. Brazil Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 143. Brazil Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Brazil Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. United Kingdom Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 146. United Kingdom Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 147. United Kingdom Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. United Kingdom Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Germany Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 150. Germany Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 151. Germany Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Germany Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. France Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 154. France Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 155. France Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. France Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Russia Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 158. Russia Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 159. Russia Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Russia Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Italy Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 162. Italy Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 163. Italy Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Italy Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Spain Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 166. Spain Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 167. Spain Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Spain Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. China Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 170. China Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 171. China Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. China Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. India Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 174. India Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 175. India Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. India Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Japan Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 178. Japan Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 179. Japan Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Japan Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Australia Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 182. Australia Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 183. Australia Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Australia Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. South Korea Heart Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 186. South Korea Heart Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 187. South Korea Heart Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. South Korea Heart Disease Diagnosis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Global Heart Disease Diagnosis Market Share, by Key Player, 2025
TABLE 190. Global Heart Disease Diagnosis Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • AliveCor Inc
  • Bio-Rad Laboratories Inc
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Danaher Corporation
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc
  • Getinge AB
  • HeartFlow Inc
  • Hitachi Ltd
  • iRhythm Technologies Inc
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Quest Diagnostics Incorporated
  • Schiller AG
  • Siemens Healthineers AG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc

Related Topics

Related Reports

Heart Failure Therapeutics Market - Global Forecast 2026-2032 - Product Image

Heart Failure Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Vasodilators for Heart Disease Market - Global Forecast 2026-2032 - Product Image

Vasodilators for Heart Disease Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Atrial Fibrillation Market - Global Forecast 2026-2032 - Product Image

Atrial Fibrillation Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Pediatric Interventional Cardiology Market - Global Forecast 2026-2032 - Product Image

Pediatric Interventional Cardiology Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Aortic Stenosis Market - Global Forecast 2026-2032 - Product Image

Aortic Stenosis Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.